These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35872628)

  • 1. Predictors of post COVID complications in patients admitted with moderate to severe COVID symptoms: A single center, prospective, observational study.
    Guliani A; Tandon A; Chakroborty A; Gupta PP
    Monaldi Arch Chest Dis; 2022 Jul; 93(2):. PubMed ID: 35872628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh.
    Mahmud R; Rahman MM; Rassel MA; Monayem FB; Sayeed SKJB; Islam MS; Islam MM
    PLoS One; 2021; 16(4):e0249644. PubMed ID: 33831043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
    Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
    Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post COVID-19 sequelae: A prospective observational study from Northern India.
    Naik S; Haldar SN; Soneja M; Mundadan NG; Garg P; Mittal A; Desai D; Trilangi PK; Chakraborty S; Begam NN; Bhattacharya B; Maher G; Mahishi N; Rajanna C; Kumar SS; Arunan B; Kirtana J; Gupta A; Patidar D; Kodan P; Sethi P; Ray A; Jorwal P; Kumar A; Nischal N; Sinha S; Biswas A; Wig N
    Drug Discov Ther; 2021 Nov; 15(5):254-260. PubMed ID: 34719599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characterization of the Persistent COVID-19 Symptoms: A Descriptive Observational Study in Primary Care.
    Rodríguez Onieva A; Vallejo Basurte C; Fernández Bersabé A; Camacho Cerro L; Valverde Bascón B; Muriel Sanjuan N; Soto Castro CA; García Morales V; Piedra Ruiz F; Hidalgo Requena A
    J Prim Care Community Health; 2023; 14():21501319231208283. PubMed ID: 37947104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up.
    Tleyjeh IM; Saddik B; AlSwaidan N; AlAnazi A; Ramakrishnan RK; Alhazmi D; Aloufi A; AlSumait F; Berbari E; Halwani R
    PLoS One; 2021; 16(12):e0260568. PubMed ID: 34874962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for post-acute sequelae of COVID-19 in hospitalized patients: An observational study based on a survey in a tertiary care center in Türkiye.
    Yıldız Y; Öztürk Şahin B; Demir MC; Demir Ş; Çiftci B; Köktürk N; Ulukavak Çiftçi T; Yurdakul AS; Yılmaz Demirci N; Aydoğdu M; Dizbay M; Oğuzülgen İK
    Tuberk Toraks; 2023 Sep; 71(3):261-272. PubMed ID: 37740629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of venous thromboembolism in coronavirus disease 2019: An experience from a single large academic center.
    Rali P; O'Corragain O; Oresanya L; Yu D; Sheriff O; Weiss R; Myers C; Desai P; Ali N; Stack A; Bromberg M; Lubitz AL; Panaro J; Bashir R; Lakhter V; Caricchio R; Gupta R; Dass C; Maruti K; Lu X; Rao AK; Cohen G; Criner GJ; Choi ET;
    J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):585-591.e2. PubMed ID: 32979557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review.
    Nasserie T; Hittle M; Goodman SN
    JAMA Netw Open; 2021 May; 4(5):e2111417. PubMed ID: 34037731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study.
    Adler L; Gazit S; Pinto Y; Perez G; Mizrahi Reuveni M; Yehoshua I; Hoffman R; Azuri J; Patalon T
    Scand J Prim Health Care; 2022 Sep; 40(3):342-349. PubMed ID: 36314555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and Characterization of Post-COVID-19 Symptoms in Hospitalized COVID-19 Survivors to Recognize Syndemic Connotations in India: Single-Center Prospective Observational Cohort Study.
    Nair CV; Moni M; Edathadathil F; A A; Prasanna P; Pushpa Raghavan R; Sathyapalan DT; Jayant A
    JMIR Form Res; 2023 Apr; 7():e40028. PubMed ID: 36920842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid.
    Paredes-Ruiz D; Gómez-Cuervo C; Gómez-Martín C; Sánchez-Guerrero Á; González-Olmedo J; López-López F; Bover-Larroya M; Yarza-Barrio R; Jara-Casas DD; Castelo-Laureiro A; Revilla-Ostolaza Y; Paz-Ares L; Lumbreras-Bermejo C; Díaz-Pedroche C
    J Thromb Thrombolysis; 2022 Feb; 53(2):471-478. PubMed ID: 33890200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae.
    Daher A; Balfanz P; Cornelissen C; Müller A; Bergs I; Marx N; Müller-Wieland D; Hartmann B; Dreher M; Müller T
    Respir Med; 2020; 174():106197. PubMed ID: 33120193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and predictors of post-COVID-19 symptoms in general practice - a registry-based nationwide study.
    Hetlevik Ø; Wensaas KA; Baste V; Emberland KE; Özgümüs T; Håberg SE; Rortveit G
    BMC Infect Dis; 2023 Oct; 23(1):721. PubMed ID: 37880583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Post-Covid Symptoms in Covid-19 Recovered Patients: A Prospective Cohort Study in a Tertiary Care Centre of South India.
    Kambhampati NT; Chithira ; PillaiM GK; Ts D; Moni M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features and predictors of severity in 1022 adults with COVID-19].
    Saldías Peñafiel F; Peñaloza Tapia A; Farías Nesvadba D; Farcas Oksenberg K; Reyes Sánchez A; Cortés Meza J; Lara Hernández B; Aguilera Fuenzalida P; Leiva Rodríguez I
    Rev Med Chil; 2020 Oct; 148(10):1387-1397. PubMed ID: 33844708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.